RP-HPLC

Definition

RP-HPLC (Reverse-Phase High-Performance Liquid Chromatography) is the reference analytical technique for separation, purification and purity control of synthetic peptides. It relies on separation by hydrophobicity, using a non-polar stationary phase and polar mobile phase — inverse of normal-phase chromatography, hence the name.

Principle and stationary phase. The RP-HPLC column is typically functionalised silica with grafted alkyl chains: C18 (octadecyl, most universal for peptides <5 kDa), C8 (octyl, moderately hydrophobic peptides), C4 (butyl, peptides and small proteins up to 20 kDa), C3/C1 or phenyl (aromatic selective retention). Typical dimensions are 250 × 4.6 mm analytical, 250 × 21.2 mm semi-preparative, 250 × 50 mm preparative. Particle size (3, 5 or 10 μm) and porosity (100-300 Å) affect resolution and capacity.

Mobile phase and gradient. The standard gradient combines water + 0.1% TFA (solvent A, acidic aqueous phase) and acetonitrile + 0.1% TFA (solvent B, organic phase), TFA acting as ion-pairing agent neutralising peptide charges and improving peak symmetry. A typical 10 to 70% B gradient over 20-40 min allows separation of standard linear peptides. UV detection at 214 nm (peptide bond) and 280 nm (Tyr, Trp) is universal; PDA, ELSD and MS detectors (coupled LC-MS) provide additional information.

Peptide applications. Analytical RP-HPLC validates batch purity (≥98% on commercial RUO peptides), identifies impurities (deletion, deamidation, oxidation, racemisation) and their relative quantification. Preparative RP-HPLC is the critical final step of SPPS production to separate target peptide from truncated sequences, TFA-adduct fragments and synthesis impurities. The technique is documented in USP <621> and Ph. Eur. 2.2.46 monographs for pharmaceutical peptide products.